"Liquid morphology": Immunochemical analysis of proteins extracted from formalin-fixed paraffin-embedded tissues: Combining proteomics with immunohistochemistry

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 1, 2011, Pages 1-9

  Becker, Karl Friedrich ^a   Taylor, Clive R ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

calibration; Immunohistochemistry; quantifiable internal reference standards; quantification of immunohistochemistry

Indexed keywords

BIOLOGICAL MARKER; FORMALDEHYDE; PARAFFIN;

ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; REPRODUCIBILITY; REVIEW;

ANIMALS; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; PARAFFIN; PRACTICE GUIDELINES AS TOPIC; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 78650842361     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181f50883     Document Type: Review

References (40)

1. Taylor CR. Immunohistological approach to tumor diagnosis. Oncology. 1978;35:189-197.
2. Taylor CR, Kledzik G. Immunohistologic techniques in surgical pathologyFa spectrum of "new" special stains. Hum Pathol. 1981;12:590-596.
3. Shi SR, Cote RJ, Taylor CR. Antigen retrieval techniques: current perspectives. J Histochem Cytochem. 2001;49:931-937.
4. Shi SR, Gu J, Taylor CR, eds. Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology. Natick, MA: BioTechniques Books, Eaton Publishing; 2000.
5. Shi SR, Taylor CR, eds. Immunohistochemistry and Antigen retrieval Based Research and Diagnosis. New Jersey, USA: Wiley; 2010.
6. Taylor CR, Cote RJ. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist. Philadelphia: Saunders Elsevier; 2006.
7. Shi SR, Liu C, Balgley MB, et al. Protein extraction from formalinfixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem. 2006;54:739-743.
8. Xu H, Yang L, Wang W, et al. Antigen retrieval for proteomic characterization of formalin-fixed and paraffin-embedded tissues. J Proteome Res. 2008;7:1098-1108.
9. Taylor CR. Quantifiable internal reference standards for immunohistochemistry: the measurement of quantity by weight. Appl Immunohistochem Mol Morphol. 2006;14:253-259.
10. Becker K-F, Schott C, Hipp S, et al. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol. 2007;211: 370-378.
11. Becker K-F, Schott C, Becker I, et al. Guided protein extraction from formalin-fixed tissues for quantitative multiplex analysis avoids detrimental effects of histologic stains. Proteomics Clin Appl. 2008;2:737-743.
12. Becker K-F, Mack H, Schott C, et al. Extraction of phosphorylated proteins from formalin-fixed cancer cells and tissues. Open Pathol J. 2008;2:46-82.
13. Taylor CR, Levenson RM. Quantification of ImmunohistochemistryFissues concerning methods, utility and semiquantitative assessment. Histopathology. 2006;49:411-424.
14. Shi SR, Balgley BM, Taylor CR. Symbiosis of immunohistochemistry and proteomics: marching to a new era. J Histochem Cytochem. In press.
15. Yaziji H, Taylor C, Goldstein N, et al, and members of the Standardization Ad-Hoc Consensus Committee. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol. 2008;16:513-520.
16. Wolff AC, Hammond EH, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131: 18-43.
17. Hanna WM, Hammond E, Taylor CR, et al. High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system. Mod Pathol. 2008;21: 1278-1280.
18. Hewitt SM, Lewis FA, Cao Y, et al. Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med. 2008;132:1929-1935.
19. Nirmalan NJ, Harnden P, Selby PJ, et al. Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges. Mol Biosyst. 2008;4:712-720.
20. Stoeckli M, Chaurand P, Hallahan DE, et al. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med. 2001;7:493-496.
21. Seeley EH, Caprioli RM. Molecular imaging of proteins in tissues by mass spectrometry. Proc Natl Acad Sci U S A. 2008;105: 18126-18131.
22. Gillespie JW, Best CJ, Bichsel VE, et al. Evaluation of non-formalin tissue fixation for molecular profiling studies. Am J Pathol. 2002;160:449-457.
23. Ahram M, Flaig MJ, Gillespie JW, et al. Evaluation of ethanolfixed, paraffin-embedded tissues for proteomic applications. Proteomics. 2003;3:413-421.
24. Espina V, Mehta AI, Winters ME, et al. Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics. 2003;3:2091-2100.
25. Ikeda K, Monden T, Kanoh T, et al. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffinembedded tissue sections. J Histochem Cytochem. 1998;46:397-403.
26. Chu WS, Liang Q, Liu J, et al. A nondestructive molecule extraction method allowing morphological and molecular analyses using a single tissue section. Lab Invest. 2005;85:1416-1428.
27. Chung JY, Lee SJ, Kris Y, et al. A well-based reverse-phase protein array applicable to extracts from formalin-fixed paraffin-embedded tissue. Proteomics Clin Appl. 2008;2:1539-1547.
28. Nirmalan NJ, Harnden P, Selby PJ, et al. Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. J Pathol. 2009;217:497-506.
29. Addis MF, Tanca A, Pagnozzi D, et al. Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics. 2009;9:3815-3823.
30. Berg D, Hipp S, Malinowsky K, et al. Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues. Eur J Cancer. 2010;46:47-55.
31. Feinberg JG. A "microspot" test for antigens and antibodies. Nature. 1961;192:985-986.
32. Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene. 2001;20:1981-1989.
33. Liotta LA, Espina V, Mehta AI, et al. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell. 2003; 3:317-325.
34. Gulmann C, Sheehan KM, Kay EW, et al. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. J Pathol. 2006;208:595-606.
35. Spurrier B, Ramalingam S, Nishizuka S. Reverse-phase protein lysate microarrays for cell signalling analysis. Nat Protoc. 2008;3: 1796-1808.
36. Sheehan KM, Calvert VS, Kay EW, et al. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics. 2005;4:346-355.
37. Becker KF, Metzger V, Hipp S, et al. Clinical proteomics: new trends for protein microarrays. Curr Med Chem. 2006;13:1831-1837.
38. Hipp S, Walch A, Schuster T, et al. Activation of epidermal growth factor receptor results in snail protein but not mRNA overexpression in endometrial cancer. J Cell MolMed. 2009;13:3858-3867.
39. Espina V, Edmiston KH, Heiby M, et al. A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics. 2008;7:1998-2018.
40. Leong ASY. Quantitative immunohistology: tissue section thickness, another glitch in the path to standardization. Appl Immunohistochem Mol Morphol. 2009;17:465-469.